GenMark Diagnostics director just picked up 2,432 shares

James Fox, a director of GenMark Diagnostics, recently acquired 2,432 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on August 07, 2014. Fox now owns 136,017 shares of the company. Fox operates out of Carlsbad, CA. Some additional info was provided as follows:

The amount reported reflects restricted stock units granted to the reporting person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on May 29, 2015. Dr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. GenMark Diagnostics next reports earnings on August 11, 2014.

To receive a free e-mail notification whenever GenMark Diagnostics makes a similar move, sign up!

Other recent filings from the company include the following:

Genmark Diagnostics Reports Third Quarter 2014 Results - Oct. 30, 2014
GenMark Diagnostics Just Filed Its Quarterly Report: The following table ... - Oct. 30, 2014
GenMark Diagnostics's President and CEO just disposed of 5,804 shares - Oct. 15, 2014
SVP of GenMark Diagnostics just disposed of 156 shares - Oct. 9, 2014
SVP of GenMark Diagnostics just disposed of 55 shares - Oct. 9, 2014

   Auto Refresh